WallStreetZenWallStreetZen

NASDAQ: KALV
Kalvista Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Kalvista Pharmaceuticals earnings were -$175.9M for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. The latest KALV earnings report on Jan 31, 2025 announced Q1 2025 earnings of -$48.5M, up 14.8% from last quarter. For the last reported fiscal year 2024 ending Apr 30, 2024, KALV reported annual earnings of -$126.6M, with 36.3% growth.

KALV earnings history

Current Revenue
$0.0
Current Earnings
-$175.9M
Current Profit Margin
0%

KALV Return on Equity

Current Company
-106.8%
Current Industry
-1.7%
Current Market
34.2%
KALV's Return on Equity (-106.8%)... subscribe to Premium to read more.
High Return on Equity Performance

KALV undefined

Current Company
-80.6%
Current Industry
0%
KALV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KALV announces earnings.

KALV undefined

Current Company
-67.41%
Current Industry
6.4%
KALV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KALV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KALV-$167.88M-$175.87MN/A-$3.77
ABUS-$68.40M-$69.92MN/A-$0.38
CVAC$169.95M$115.21MN/A$0.52
MRVI-$42.14M-$144.85MN/A-$1.05
TRVI-$47.79M-$47.91MN/A-$0.47
View Top Biotech Stocks

Kalvista Pharmaceuticals Earnings Reports & History FAQ

What were Kalvista Pharmaceuticals's earnings last quarter?

On KALV's earnings call on Invalid Date, Kalvista Pharmaceuticals (NASDAQ: KALV) reported Q4 2024 earnings per share (EPS) of -$0.92, up 9.52% year over year. Total KALV earnings for the quarter were -$48.51 million. In the same quarter last year, Kalvista Pharmaceuticals's earnings per share (EPS) was -$0.84.

If you're new to stock investing, here's how to buy Kalvista Pharmaceuticals stock.

Is Kalvista Pharmaceuticals profitable or losing money?

As of the last Kalvista Pharmaceuticals earnings report, Kalvista Pharmaceuticals is currently losing money. Kalvista Pharmaceuticals's net profit (also called net income) for the twelve months ending Jan 31, 2025 was -$175.87 million, a 62.39% increase year over year.

What was KALV's earnings growth in the past year?

As of Kalvista Pharmaceuticals's earnings date in Invalid Date, Kalvista Pharmaceuticals's earnings has grown year over year. KALV earnings in the past year totalled -$175.87 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.